YanAn Bicon Pharmaceutical Listed Company
Simbols: 002411.SZ
SHZ
0.62
CNYTirgus cena šodien
-0.5881
P/E koeficients
-0.0152
PEG koeficients
950.01M
MRK Cap
- 0.00%
DIV ienesīgums
YanAn Bicon Pharmaceutical Listed Company (002411-SZ) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 3267.61 | 950.2 | 842.6 | 710.4 | |||||||||||||||||
balance-sheet.row.short-term-investments | 194.74 | 73.1 | -240.1 | -216.7 | |||||||||||||||||
balance-sheet.row.net-receivables | 19813.77 | 4260.2 | 5748.3 | 5945.8 | |||||||||||||||||
balance-sheet.row.inventory | 3740.51 | 788.2 | 978.6 | 763.9 | |||||||||||||||||
balance-sheet.row.other-current-assets | 319.4 | 76.3 | 106.9 | 85.1 | |||||||||||||||||
balance-sheet.row.total-current-assets | 27141.29 | 6074.9 | 7676.5 | 7505.3 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 18876.13 | 2910 | 6651.1 | 8593.4 | |||||||||||||||||
balance-sheet.row.goodwill | 6512.07 | 1614.7 | 1641.3 | 1641.3 | |||||||||||||||||
balance-sheet.row.intangible-assets | 2412.53 | 531 | 670.9 | 774.6 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 8924.59 | 2145.8 | 2312.2 | 2416 | |||||||||||||||||
balance-sheet.row.long-term-investments | -30.09 | -15 | 288.5 | 261.6 | |||||||||||||||||
balance-sheet.row.tax-assets | 2272.59 | 984.9 | 151.9 | 171.9 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 9353.57 | 2761.1 | 1643.1 | 259.3 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 39396.78 | 8786.7 | 11046.8 | 11702.2 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 66538.08 | 14861.6 | 18723.3 | 19207.4 | |||||||||||||||||
balance-sheet.row.account-payables | 7878.36 | 1892 | 2036.3 | 2142.7 | |||||||||||||||||
balance-sheet.row.short-term-debt | 10572.87 | 1553 | 4617.7 | 4005.3 | |||||||||||||||||
balance-sheet.row.tax-payables | 3673.99 | 1062.4 | 1031.9 | 779 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 2554.55 | 231.9 | 283.2 | 1084.8 | |||||||||||||||||
Deferred Revenue Non Current | 504.79 | 126.1 | 132.9 | 139.2 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 58 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 14694.58 | 4597 | 20.2 | 46.3 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 4284.47 | 656.7 | 727.6 | 1285.9 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 55.85 | 12.6 | 29.9 | 19.3 | |||||||||||||||||
balance-sheet.row.total-liab | 37430.28 | 8698.7 | 10650.4 | 10276.4 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 7113.22 | 1778.3 | 1778.3 | 1778.3 | |||||||||||||||||
balance-sheet.row.retained-earnings | -1660.9 | -1317.7 | 247.4 | 1204.5 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 21853.18 | 5312.8 | 5601.3 | 5522.6 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 27305.5 | 5773.3 | 7627 | 8505.5 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 66538.08 | 14861.6 | 18723.3 | 19207.4 | |||||||||||||||||
balance-sheet.row.minority-interest | 1802.3 | 389.5 | 446 | 425.6 | |||||||||||||||||
balance-sheet.row.total-equity | 29107.8 | 6162.9 | 8073 | 8931 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 66538.08 | - | - | - | |||||||||||||||||
Total Investments | 213.13 | 58.1 | 48.4 | 44.9 | |||||||||||||||||
balance-sheet.row.total-debt | 13127.42 | 1784.9 | 4900.9 | 5090.1 | |||||||||||||||||
balance-sheet.row.net-debt | 10006.06 | 907.8 | 4058.2 | 4379.7 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -1560.63 | -1054.7 | -659.7 | -1054.3 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 350.1 | 403.3 | 338.9 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 2112.3 | -732.8 | -1104.2 | |||||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.inventory | 0 | -8.4 | -212.8 | -1.6 | |||||||||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.other-working-capital | 0 | 2120.8 | -520 | -1102.6 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 1517.5 | 1590.6 | 1454.5 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -1560.63 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -1498.5 | -1452.8 | -281.1 | -143.7 | |||||||||||||||||
cash-flows.row.acquisitions-net | 1335.58 | 1335.6 | 0 | 0.1 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -25.7 | -25.6 | 205.5 | -0.3 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0.01 | 996 | 3.8 | 0.7 | |||||||||||||||||
cash-flows.row.other-investing-activites | 985.62 | -10.3 | 132.8 | 1194.8 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 797.01 | 842.8 | 60.9 | 1051.7 | |||||||||||||||||
cash-flows.row.debt-repayment | -3769.74 | -3339 | -647.6 | -3023.1 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | -2054.05 | -2021.4 | -200.1 | -431.2 | |||||||||||||||||
cash-flows.row.other-financing-activites | 2695.35 | 2222.5 | 460.1 | 2738.8 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -3128.44 | -3137.9 | -387.6 | -715.5 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 23.75 | 23.7 | -1 | -0.4 | |||||||||||||||||
cash-flows.row.net-change-in-cash | -227.08 | 653.9 | 273.8 | -29.3 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 2538.32 | 1154.2 | 500.7 | 226.8 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 2765.4 | 500.3 | 226.8 | 256.1 | |||||||||||||||||
cash-flows.row.operating-cash-flow | -1560.63 | 2925.3 | 601.4 | -365 | |||||||||||||||||
cash-flows.row.capital-expenditure | -1498.5 | -1452.8 | -281.1 | -143.7 | |||||||||||||||||
cash-flows.row.free-cash-flow | -3059.13 | 1472.4 | 320.3 | -508.8 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 7057.74 | 8106.3 | 7663.2 | 6939.5 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 5817.12 | 6075.1 | 5311.9 | 5613.1 | |||||||||||||||||
income-statement-row.row.gross-profit | 1240.61 | 2031.2 | 2351.2 | 1326.4 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 127.63 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 34.99 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 290.11 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 1153.16 | 1157.5 | 325.1 | 306.9 | |||||||||||||||||
income-statement-row.row.operating-expenses | 1605.89 | 1719.5 | 856.8 | 946.7 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 7423.02 | 7794.6 | 6168.7 | 6559.8 | |||||||||||||||||
income-statement-row.row.interest-income | -4.19 | -6 | 16 | 20.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 201.51 | 283.7 | 357.9 | 1135.6 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 290.11 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -518.6 | -2001.5 | -1587.9 | -2048.9 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 1153.16 | 1157.5 | 325.1 | 306.9 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -518.6 | -2001.5 | -1587.9 | -2048.9 | |||||||||||||||||
income-statement-row.row.interest-expense | 201.51 | 283.7 | 357.9 | 1135.6 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 1448.87 | 350.1 | 403.3 | 338.9 | |||||||||||||||||
income-statement-row.row.ebitda-caps | -271.28 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | -1720.15 | 342.9 | 1219.9 | 930.6 | |||||||||||||||||
income-statement-row.row.income-before-tax | -2238.75 | -1658.6 | -368 | -1118.3 | |||||||||||||||||
income-statement-row.row.income-tax-expense | -692.52 | -603.9 | 291.7 | -45.5 | |||||||||||||||||
income-statement-row.row.net-income | -1560.63 | -1054.7 | -659.7 | -1072.8 |
Biežāk uzdotie jautājumi
Kas ir YanAn Bicon Pharmaceutical Listed Company (002411.SZ) kopējie aktīvi?
YanAn Bicon Pharmaceutical Listed Company (002411.SZ) kopējie aktīvi ir 14861598713.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir 3146759640.000.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.155.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir -1.981.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir -0.303.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir -0.342.
Kāda ir YanAn Bicon Pharmaceutical Listed Company (002411.SZ) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir -1054699022.740.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 1784935683.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 1719493052.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 489995625.000.